Cellebrite DI Ltd. (CLBT)
(Delayed Data from NSDQ)
$12.41 USD
+0.01 (0.08%)
Updated Aug 6, 2024 03:59 PM ET
After-Market: $12.42 +0.01 (0.08%) 6:18 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$12.41 USD
+0.01 (0.08%)
Updated Aug 6, 2024 03:59 PM ET
After-Market: $12.42 +0.01 (0.08%) 6:18 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Zacks News
Cellebrite (CLBT) and LiveRamp (RAMP) Are Aggressive Growth Stocks
by Brian Bolan
Two more names for your aggressive growth stock radar screen.
Are You Looking for a Top Momentum Pick? Why Cellebrite DI Ltd. (CLBT) is a Great Choice
by Zacks Equity Research
Does Cellebrite DI Ltd. (CLBT) have what it takes to be a top stock pick for momentum investors? Let's find out.
5 Solid Relative Price Strength Opportunities for Investors
by Nilanjan Choudhury
CLBT, BWAY, TAST, RCL and GIC are five stocks with explosive relative price strength.
Earnings Estimates Moving Higher for Cellebrite DI Ltd. (CLBT): Time to Buy?
by Zacks Equity Research
Cellebrite DI Ltd. (CLBT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Best Momentum Stocks to Buy for November 17th
by Zacks Equity Research
FINW, PGR and CLBT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 17, 2023.
These Small-Cap Stocks are a Highlight of This Week's Earnings Lineup
by Shaun Pruitt
This week's earnings lineup has been highlighted by quite a few small-cap stocks that have strengthening prospects after posting impressive quarterly results on Tuesday.
Is Cellebrite DI Ltd. (CLBT) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how Cellebrite DI Ltd. (CLBT) and Futu Holdings Limited Sponsored ADR (FUTU) have performed compared to their sector so far this year.
Has Copart (CPRT) Outpaced Other Business Services Stocks This Year?
by Zacks Equity Research
Here is how Copart, Inc. (CPRT) and Cellebrite DI Ltd. (CLBT) have performed compared to their sector so far this year.
Paymentus Holdings, Inc. (PAY) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Paymentus (PAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Cellebrite DI Ltd. (CLBT) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Cellebrite DI Ltd. (CLBT) delivered earnings and revenue surprises of 66.67% and 5.83%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Cellebrite DI Ltd. (CLBT) Q1 Earnings Match Estimates
by Zacks Equity Research
Cellebrite DI Ltd. (CLBT) delivered earnings and revenue surprises of 0% and 2.61%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
V2X (VVX) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
V2X (VVX) delivered earnings and revenue surprises of 23.08% and 7.04%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Does Cellebrite DI Ltd. (CLBT) Have the Potential to Rally 28.35% as Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at a 28.4% upside potential for Cellebrite DI Ltd. (CLBT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
VNT or CLBT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
VNT vs. CLBT: Which Stock Is the Better Value Option?
Cellebrite DI Ltd. (CLBT) Misses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Cellebrite DI Ltd. (CLBT) delivered earnings and revenue surprises of -66.67% and 1.82%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Sunlight Financial Holdings Inc. (SUNL) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Sunlight Financial Holdings Inc. (SUNL) delivered earnings and revenue surprises of -6.67% and 25.53%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Mogo Inc (MOGO) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Mogo Inc (MOGO) delivered earnings and revenue surprises of 20% and 2.72%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Boxlight Corporation (BOXL) Beats Q3 Earnings Estimates
by Zacks Equity Research
Boxlight Corporation (BOXL) delivered earnings and revenue surprises of 50% and 3.50%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Coursera (COUR) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Coursera (COUR) delivered earnings and revenue surprises of 36.36% and 6.24%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
ShotSpotter (SSTI) Surges 3.6%: Is This an Indication of Further Gains?
by Zacks Equity Research
ShotSpotter (SSTI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
IQV vs. CLBT: Which Stock Is the Better Value Option?
by Zacks Equity Research
IQV vs. CLBT: Which Stock Is the Better Value Option?
VNT vs. CLBT: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
VNT vs. CLBT: Which Stock Is the Better Value Option?
BCOR or CLBT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BCOR vs. CLBT: Which Stock Is the Better Value Option?
Wall Street Analysts Believe Cellebrite DI Ltd. (CLBT) Could Rally 102%: Here's is How to Trade
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 102% in Cellebrite DI Ltd. (CLBT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Here's Why Cellebrite DI Ltd. (CLBT) Could be Great Choice for a Bottom Fisher
by Zacks Equity Research
Cellebrite DI Ltd. (CLBT) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.